Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Bulevirtide Linked to Less Decompensation in Chronic Hep D With Cirrhosis

(MedPage Today) -- In patients with chronic hepatitis delta (CHD) with cirrhosis, treatment with bulevirtide (Hepcludex) was associated with lower risk of liver decompensation, according to results from a European retrospective study. Among more...

Bulevirtide Linked to Less Decompensation in Chronic Hep D With Cirrhosis

We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.

Read the original at medpagetoday.com →

More in Health & Medicine

More from Monday 9 November →